share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股sec公告 ·  06/12 04:20
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 06/11/2024, as per the latest filing. The shares, valued at approximately $96,762.82, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 85,896 Class A shares were sold by Borgeson, generating gross proceeds of $803,931.52. The upcoming sale reflects ongoing trading activity by the director, with the specific intent and plan for this sale having been adopted on 08/18/2023.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 06/11/2024, as per the latest filing. The shares, valued at approximately $96,762.82, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 85,896 Class A shares were sold by Borgeson, generating gross proceeds of $803,931.52. The upcoming sale reflects ongoing trading activity by the director, with the specific intent and plan for this sale having been adopted on 08/18/2023.
Recursion Pharmaceuticals, Inc.董事Blake Borgeson計劃在2024年06月11日出售11,447股A類股，根據最新文件。這些股份的價值約爲96,762.82美元，最初是作爲發行人補償的創始股份於2016年09月01日獲得的。此次計劃的銷售是在過去三個月的一系列交易之後，Borgeson已經賣出了總計85,896股A類股，獲得了803,931.52美元的總收益。即將到來的銷售反映了董事持續的交易活動，這次銷售的具體意圖和計劃已於2023年08月18日採納。
Recursion Pharmaceuticals, Inc.董事Blake Borgeson計劃在2024年06月11日出售11,447股A類股，根據最新文件。這些股份的價值約爲96,762.82美元，最初是作爲發行人補償的創始股份於2016年09月01日獲得的。此次計劃的銷售是在過去三個月的一系列交易之後，Borgeson已經賣出了總計85,896股A類股，獲得了803,931.52美元的總收益。即將到來的銷售反映了董事持續的交易活動，這次銷售的具體意圖和計劃已於2023年08月18日採納。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。